Literature DB >> 32967038

Friend or foe of innate lymphoid cells in inflammation-associated cardiovascular disease.

Xiangmei Gong1,2, Lin Xia1,3, Zhaoliang Su1,2,4.   

Abstract

As a distinctive population of leucocytes, innate lymphoid cells (ILCs) participate in immune-mediated diseases and play crucial roles in tissue remodelling after injury. ILC lineages can be divided into helper ILCs and cytotoxic ILCs. Most helper ILCs are integrated into the fabric of tissues and produce different types of cytokines involving in the pathogenesis of many kinds of cardiovascular disease and form intricate response circuits with adaptive immune cells. However, the specific phenotype and function of helper ILC subsets in cardiovascular diseases are still poorly understood. In this review, we firstly highlight the distribution of helper ILCs in cardiovascular system and further discuss the potential contribution of helper ILCs in inflammation-associated cardiovascular disease.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiovascular disease; cardiovascular system; innate lymphoid cells

Mesh:

Year:  2020        PMID: 32967038      PMCID: PMC7968396          DOI: 10.1111/imm.13271

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  133 in total

1.  Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis.

Authors:  Cécile Braudeau; Karine Amouriaux; Antoine Néel; Guillaume Herbreteau; Nina Salabert; Marie Rimbert; Jérôme C Martin; Caroline Hémont; Mohamed Hamidou; Régis Josien
Journal:  J Autoimmun       Date:  2016-04-18       Impact factor: 7.094

2.  Clinical presentation and diagnosis of myocarditis.

Authors:  Alida L P Caforio; Renzo Marcolongo; Cristina Basso; Sabino Iliceto
Journal:  Heart       Date:  2015-06-24       Impact factor: 5.994

3.  Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance.

Authors:  Timothy E O'Sullivan; Moritz Rapp; Xiying Fan; Orr-El Weizman; Priya Bhardwaj; Nicholas M Adams; Thierry Walzer; Andrew J Dannenberg; Joseph C Sun
Journal:  Immunity       Date:  2016-08-02       Impact factor: 31.745

4.  Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.

Authors:  Christoph S N Klose; Melanie Flach; Luisa Möhle; Leif Rogell; Thomas Hoyler; Karolina Ebert; Carola Fabiunke; Dietmar Pfeifer; Veronika Sexl; Diogo Fonseca-Pereira; Rita G Domingues; Henrique Veiga-Fernandes; Sebastian J Arnold; Meinrad Busslinger; Ildiko R Dunay; Yakup Tanriver; Andreas Diefenbach
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

5.  Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.

Authors:  G Christian Baldeviano; Jobert G Barin; Monica V Talor; Sachin Srinivasan; Djahida Bedja; Dongfeng Zheng; Kathleen Gabrielson; Yoichiro Iwakura; Noel R Rose; Daniela Cihakova
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

6.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

Authors:  Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

7.  IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.

Authors:  Yujie Guo; Weifeng Wu; Zhihong Cen; Xiaomo Li; Qing Kong; Qiuxi Zhou
Journal:  Virol J       Date:  2014-12-30       Impact factor: 4.099

8.  IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells.

Authors:  Yuefeng Huang; Liying Guo; Jin Qiu; Xi Chen; Jane Hu-Li; Ulrich Siebenlist; Peter R Williamson; Joseph F Urban; William E Paul
Journal:  Nat Immunol       Date:  2014-12-22       Impact factor: 25.606

9.  Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.

Authors:  Ari B Molofsky; Frédéric Van Gool; Hong-Erh Liang; Steven J Van Dyken; Jesse C Nussbaum; Jinwoo Lee; Jeffrey A Bluestone; Richard M Locksley
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

10.  Type 2 innate lymphoid cells control eosinophil homeostasis.

Authors:  Jesse C Nussbaum; Steven J Van Dyken; Jakob von Moltke; Laurence E Cheng; Alexander Mohapatra; Ari B Molofsky; Emily E Thornton; Matthew F Krummel; Ajay Chawla; Hong-Erh Liang; Richard M Locksley
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  2 in total

Review 1.  Innate Lymphoid Cells and Myocardial Infarction.

Authors:  Wenling Yang; Jibin Lin; Jin Zhou; Yuqi Zheng; Shijiu Jiang; Shaolin He; Dazhu Li
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 2.  Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies.

Authors:  Magali Seguret; Eva Vermersch; Charlène Jouve; Jean-Sébastien Hulot
Journal:  Biomedicines       Date:  2021-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.